Actively Recruiting
Effect of PCI on Clinical Prognosis of Chronic Coronary Artery Occlusion
Led by The First Affiliated Hospital with Nanjing Medical University · Updated on 2024-12-27
258
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Coronary chronic total occlusions (CTOs) are considered to increase the risk of adverse clinical outcomes. The purpose of this study was to evaluate whether long-term clinical outcomes could be improved by successful percutaneous coronary intervention (PCI) over optimal medical therapy (OMT) in CTO patients.
CONDITIONS
Official Title
Effect of PCI on Clinical Prognosis of Chronic Coronary Artery Occlusion
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with at least one coronary chronic total occlusion lesion treated at the hospital between January 2011 and December 2017
You will not qualify if you...
- Patients with ST-segment elevation myocardial infarction (STEMI)
- History of coronary artery bypass grafting (CABG)
- Cardiogenic shock
- Malignant tumor
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The First Affiliated Hospital with Nanjing Medical University
Nanjing, Jiangsu, China, 210009
Actively Recruiting
Research Team
M
Mei Wang
CONTACT
L
Lei Jiang
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here